Top Markets
Coin of the day
Anhui Anke Biotechnology (Group) Co., Ltd. Anhui Anke Biotechnology (Group) Co., Ltd.

Anhui Anke Biotechnology (Group) Co., Ltd.

300009
Xếp hạng trong cổ phiếu #6265
Anhui Anke Biotechnology (Group) Co., Ltd. is engaged in the research,... Anhui Anke Biotechnology (Group) Co., Ltd. is engaged in the research, manufacturing, and global distribution of pharmaceutical goods, serving both domestic Chinese and international markets. Its flagship offerings include Ansomone, a brand of recombinant human growth hormone administered via injection, and the Anterferon line, which comprises recombinant human interferon alpha 2b in various forms such as lyophilized powder, liquid, and prefilled syringes for injection, alongside creams, eye drops, and suppositories. The company also supplies an array of diagnostic kits, including those for detecting anti-sperm antibodies, performing semen leukocyte peroxidase staining, single-use semen processing, sperm hypo-osmotic staining, assessing sperm viability, analyzing sperm morphology, determining sperm acrosin levels, identifying sperm DNA fragmentation, and for leptin and immunohistochemical analyses. Furthermore, their product portfolio extends to adhesive bandages, liquid oral medications, various topical formulations (including creams and ointments), active pharmaceutical ingredients (APIs) derived from peptides, cosmetic and anti-aging treatments, and synthetic pharmaceutical compounds available as powders, dripping pills, and both tablets and capsules. Moreover, Anke Biotechnology offers genetic testing solutions, encompassing kits for autosomal, sex chromosome, and combined autosomal and sex chromosome analyses, along with complete paternity testing packages. They also develop biological immunotherapy treatments for tumors and provide specialized DNA testing services. Established in 2000, the firm's headquarters are situated in Hefei, China.
Giá cổ phiếu
$1.28
Vốn hóa thị trường
$2.13B
Thay đổi (1 ngày)
0.34%
Thay đổi (1 năm)
-18.11%
Quốc gia
CN
Giao dịch Anhui Anke Biotechnology (Group) Co., Ltd. (300009)

Danh mục

Lịch sử chia tách cổ phiếu của Anhui Anke Biotechnology (Group) Co., Ltd. (300009)
Cổ phiếu Anhui Anke Biotechnology (Group) Co., Ltd. (mã: 300009) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 27, 2026.
Một cổ phiếu 300009 mua trước ngày Aug 27, 2026 hiện tương đương với 0 cổ phiếu 300009.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH